C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.
about
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumSerum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal typeC-reactive protein as a marker of melanoma progression.Evaluation correlates C-reactive protein with advanced stage Hodgkin's lymphoma and response to treatment in a tertiary university hospital in Brazil.Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study.The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patientsA systematic review of the association between circulating concentrations of C reactive protein and cancerPrognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria.Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia.Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.Prognostic role of pre-transplantation serum C-reactive protein levels in patients with acute leukemia undergoing myeloablative allogeneic stem cell transplantation.Evaluation of the modified Glasgow Prognostic Score to predict outcome in dogs with newly diagnosed lymphoma.Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.
P2860
Q28219326-A8DAB7D9-616E-47EA-A196-F6EA81C766B9Q34749502-B28449A0-4372-4ED4-9CB8-B0F672B55FA7Q35419890-A4EA4921-7C7E-46BD-AD7A-E9DB565BF6C8Q35901947-85B27405-94BC-425A-AEFA-E7244E0C8B8CQ36003614-423095EB-7DF1-46DD-BB1A-28C26D8ECBAAQ36298727-7DC9BED1-C955-4B53-9C0C-48E512DE943AQ36910671-F63CB32B-99DA-4A1A-A4FA-812A5723DF85Q37077176-A9D813D9-BCF0-460F-BA6B-8AE0B9E447B4Q40495494-810F5564-5D82-44C7-8657-C0A8B3EE10A1Q42283444-9BBD4C8D-4819-477B-80F7-6669AF0FF3A1Q43856953-073993E5-B538-4EE8-B89F-9699871F2E6BQ46424382-C85E52B4-111B-4E07-AF92-556806EC6457Q50895748-5B11817C-0D9A-48E2-A85C-5C87C1D26CF4Q55315179-B92DF773-4983-43AA-A4FC-E6E6911079E8
P2860
C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
C-reactive protein (CRP) as tu ...... patients with Hodgkin disease.
@en
type
label
C-reactive protein (CRP) as tu ...... patients with Hodgkin disease.
@en
prefLabel
C-reactive protein (CRP) as tu ...... patients with Hodgkin disease.
@en
P2093
P356
P1476
C-reactive protein (CRP) as tu ...... patients with Hodgkin disease.
@en
P2093
Andrea Berghold
Annemarie Wieland
Christian Urban
Georg Mann
Reinhold Kerbl
Wolfgang Schwinger
P356
10.1002/MPO.10286
P577
2003-07-01T00:00:00Z